PFBT
NTLA icon

Parkside Financial Bank & Trust’s Intellia Therapeutics NTLA Stock Holding History

Parkside Financial Bank & Trust’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2K Hold
118
– – ﹤0.01% 2186
2026
Q1 		$1.51K Buy
118
+53
+82% +$675 ﹤0.01% 2210
2025
Q4 		$585 Sell
65
-24
-27% -$330 ﹤0.01% 2537
2025
Q3 		$1.54K Buy
89
+34
+62% +$419 ﹤0.01% 2114
2025
Q2 		$516 Sell
55
-45
-45% -$370 ﹤0.01% 2535
2025
Q1 		$709 Buy
+100
New +$1.01K ﹤0.01% 2220

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Parkside Financial Bank & Trust's NTLA Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Intellia Therapeutics (NTLA) position steady in Q2 2026 at 118 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2186.

Parkside Financial Bank & Trust first reported a position in NTLA in Q1 2025 and has held it in 6 quarters since. 328 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Parkside Financial Bank & Trust held 118 shares of Intellia Therapeutics worth $2K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Intellia Therapeutics share count unchanged in Q2 2026.
  • Intellia Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2186 holding.
  • Parkside Financial Bank & Trust first reported a position in Intellia Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 328 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.